Jeffrey Arcara
Corporate Officer/Principal at CORVUS PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-06-29
Jeffrey Arcara active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2024-02-05 | - |
Career history of Jeffrey Arcara
Former positions of Jeffrey Arcara
| Companies | Position | Start | End |
|---|---|---|---|
Neuromed Pharmaceuticals Ltd.
 Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC. | Corporate Officer/Principal | - | 2010-01-26 |
Training of Jeffrey Arcara
| University of Wisconsin | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Neuromed Pharmaceuticals Ltd.
Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Arcara
- Experience
